JP2024524701A5 - - Google Patents

Info

Publication number
JP2024524701A5
JP2024524701A5 JP2024502063A JP2024502063A JP2024524701A5 JP 2024524701 A5 JP2024524701 A5 JP 2024524701A5 JP 2024502063 A JP2024502063 A JP 2024502063A JP 2024502063 A JP2024502063 A JP 2024502063A JP 2024524701 A5 JP2024524701 A5 JP 2024524701A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
crystal
film
tablet
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024502063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524701A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/070063 external-priority patent/WO2023285706A1/en
Publication of JP2024524701A publication Critical patent/JP2024524701A/ja
Publication of JP2024524701A5 publication Critical patent/JP2024524701A5/ja
Pending legal-status Critical Current

Links

JP2024502063A 2021-07-16 2022-07-18 ２－（３－（４－（１ｈ－インダゾール－５－イルアミノ）キナゾリン－２－イル）フェノキシ）－ｎ－イソプロピルアセトアミドメタンスルホン酸塩の固体形態 Pending JP2024524701A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21186105.9 2021-07-16
EP21186105 2021-07-16
EP21199739.0 2021-09-29
EP21199739 2021-09-29
PCT/EP2022/070063 WO2023285706A1 (en) 2021-07-16 2022-07-18 Solid-state forms of 2-(3-(4-(1h-indazol-5-ylamino)quinazolin-2-yl )phenoxy)-n- isopropylacetamide methane sulfonic acid salt

Publications (2)

Publication Number Publication Date
JP2024524701A JP2024524701A (ja) 2024-07-05
JP2024524701A5 true JP2024524701A5 (https=) 2025-07-28

Family

ID=82850759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502063A Pending JP2024524701A (ja) 2021-07-16 2022-07-18 ２－（３－（４－（１ｈ－インダゾール－５－イルアミノ）キナゾリン－２－イル）フェノキシ）－ｎ－イソプロピルアセトアミドメタンスルホン酸塩の固体形態

Country Status (4)

Country Link
US (1) US20240343712A1 (https=)
EP (1) EP4370205A1 (https=)
JP (1) JP2024524701A (https=)
WO (1) WO2023285706A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024100601A1 (en) 2022-11-11 2024-05-16 Assia Chemical Industries Ltd. Solid state forms of belumosudil and processes for preparation thereof
CN117603194A (zh) * 2023-10-30 2024-02-27 南京科默生物医药有限公司 一种甲磺酸贝舒地尔的晶型及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
WO2008054599A2 (en) 2006-09-27 2008-05-08 Surface Logix, Inc. Rho kinase inhibitors
PL2903618T3 (pl) 2012-10-05 2022-09-19 Kadmon Corporation, Llc Inhibitory kinazy rho
JP2016502502A (ja) 2012-10-05 2016-01-28 カドモン コーポレイション，リミティド ライアビリティ カンパニー 眼疾患の治療
EP3875078A1 (en) * 2020-03-06 2021-09-08 Dompe' Farmaceutici S.P.A. Compounds for the treatment of covid-19
HRP20241789T1 (hr) * 2020-07-22 2025-03-14 Assia Chemical Industries Ltd. Čvrsti oblici belumosudila i soli belumosudila
WO2022170864A1 (zh) * 2021-02-09 2022-08-18 苏州科睿思制药有限公司 Belumosudil甲磺酸盐的晶型及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP6162197B2 (ja) 即時／遅延ドラッグデリバリー
JP6162196B2 (ja) 遅延性持続ドラッグデリバリー
JP6165824B2 (ja) パルス状薬剤放出
JP7456721B2 (ja) ５－メチル－１－フェニル－２－（１ｈ）－ピリドンの顆粒製剤及びその製造方法
JP6043281B2 (ja) ４−アミノ−５−フルオロ−３−［６−（４−メチルピペラジン−１−イル）−１ｈ−ベンズイミダゾール−２−イル］−１ｈ−キノリン−２−オンラクテート一水和物を含む医薬組成物
JP2024524701A5 (https=)
CN106414466A (zh) 替诺福韦艾拉酚胺复合物及其制备方法和用途
JP2022511029A5 (https=)
KR102233757B1 (ko) 유기 화합물의 제제
JP2009506014A (ja) イマチニブメシレートのデルタおよびイプシロン結晶形
CN1970547B (zh) 非布司他的晶型及其制备方法
JP7665702B2 (ja) アキシチニブを含有する医薬組成物
WO2008020820A2 (en) Pharmaceutical compositions comprising aripiprazole
JP2025506374A5 (https=)
CN111699190A (zh) 比卡格韦钠的晶形
TWI910222B (zh) 為單片基質錠劑形式之控釋型含瑞巴派特醫藥組成物及其製備方法
EP3217964A1 (en) Composition
JP2025527471A5 (https=)
JP2024525954A5 (https=)
JP2024500545A5 (https=)
JP7506475B2 (ja) フェブキソスタット製剤
WO2022143168A1 (zh) 含有吡咯喹啉醌三锂盐九水化合物的药物组合物、胶囊剂及其制备方法
JP2022541178A5 (https=)
JP2023516358A (ja) キナーゼ阻害剤の医薬組成物
JP2022541178A (ja) （ｓ）－３－アミノ－６－メトキシ－ｎ－（３，３，３－トリフルオロ－２－ヒドロキシ－２－メチルプロピル）－５－（トリフルオロメチル）ピコリンアミド製剤